Literature DB >> 10587514

Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions.

B Dubois1, S Masure, U Hurtenbach, L Paemen, H Heremans, J van den Oord, R Sciot, T Meinhardt, G Hämmerling, G Opdenakker, B Arnold.   

Abstract

Regulated expression of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) plays a role in various physiological processes. To determine in vivo how unbalanced expression of these factors can promote or affect the course of pathologies, we knocked out the mouse gelatinase B gene by replacing the catalytic and zinc-binding domains with an antisense-oriented neomycin resistance gene. Adult gelatinase B-deficient mice and wild-type controls could be induced to develop experimental autoimmune encephalomyelitis (EAE) with similar scores for neurologic disease, blood-brain barrier permeability, and central nervous system histopathology. However, whereas diseased control animals showed necrotizing tail lesions with hyperplasia of osteocartilaginous tissue, adult gelatinase B-deficient mice were resistant to this tail pathology. Gelatinase B-deficient mice younger than 4 weeks of age were significantly less susceptible to the development of EAE than were age matched controls and, even as they aged, they remained resistant to tail lesions. These data illustrate that gelatinase B expression plays a role in the development of the immune system and that, in ontogenesis, the propensity to develop autoimmunity is altered by the absence of this MMP.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10587514      PMCID: PMC409857          DOI: 10.1172/JCI6886

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  57 in total

1.  Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8.

Authors:  S Masure; P Proost; J Van Damme; G Opdenakker
Journal:  Eur J Biochem       Date:  1991-06-01

2.  Matrix metalloproteinases degrade myelin basic protein.

Authors:  S Chandler; R Coates; A Gearing; J Lury; G Wells; E Bone
Journal:  Neurosci Lett       Date:  1995-12-15       Impact factor: 3.046

3.  Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin.

Authors:  J J van den Oord; L Paemen; G Opdenakker; C de Wolf-Peeters
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

4.  Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions.

Authors:  A Maeda; R A Sobel
Journal:  J Neuropathol Exp Neurol       Date:  1996-03       Impact factor: 3.685

5.  Prevention of acute autoimmune encephalomyelitis and abrogation of relapses in murine models of multiple sclerosis by the protease inhibitor D-penicillamine.

Authors:  K Norga; L Paemen; S Masure; C Dillen; H Heremans; A Billiau; H Carton; L Cuzner; T Olsson; J Van Damme
Journal:  Inflamm Res       Date:  1995-12       Impact factor: 4.575

6.  Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis.

Authors:  B C Kieseier; R Kiefer; J M Clements; K Miller; G M Wells; T Schweitzer; A J Gearing; H P Hartung
Journal:  Brain       Date:  1998-01       Impact factor: 13.501

7.  Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40).

Authors:  J R Backstrom; G P Lim; M J Cullen; Z A Tökés
Journal:  J Neurosci       Date:  1996-12-15       Impact factor: 6.167

8.  Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases.

Authors:  K Gijbels; R E Galardy; L Steinman
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

9.  Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing.

Authors:  U Schönbeck; F Mach; P Libby
Journal:  J Immunol       Date:  1998-10-01       Impact factor: 5.422

10.  Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid.

Authors:  Z Liu; J M Shipley; T H Vu; X Zhou; L A Diaz; Z Werb; R M Senior
Journal:  J Exp Med       Date:  1998-08-03       Impact factor: 14.307

View more
  73 in total

1.  Gelatinase B deficiency impairs reproduction.

Authors:  B Dubois; B Arnold; G Opdenakker
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

2.  Circular trimers of gelatinase B/matrix metalloproteinase-9 constitute a distinct population of functional enzyme molecules differentially regulated by tissue inhibitor of metalloproteinases-1.

Authors:  Jennifer Vandooren; Benjamin Born; Inna Solomonov; Ewa Zajac; Radka Saldova; Michael Senske; Estefanía Ugarte-Berzal; Erik Martens; Philippe E Van den Steen; Jo Van Damme; Angeles Garcia-Pardo; Matheus Froeyen; Elena I Deryugina; James P Quigley; Søren K Moestrup; Pauline M Rudd; Irit Sagi; Ghislain Opdenakker
Journal:  Biochem J       Date:  2015-01-15       Impact factor: 3.857

3.  Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice.

Authors:  Stephen J Crocker; Jason K Whitmire; Ricardo F Frausto; Parntip Chertboonmuang; Paul D Soloway; J Lindsay Whitton; Iain L Campbell
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

4.  Cleavage of myelin associated glycoprotein by matrix metalloproteinases.

Authors:  Elizabeth Milward; Kee Jun Kim; Arek Szklarczyk; Thien Nguyen; Giorgia Melli; Mamatha Nayak; Deepa Deshpande; Chantel Fitzsimmons; Ahmet Hoke; Douglas Kerr; John W Griffin; Peter A Calabresi; Katherine Conant
Journal:  J Neuroimmunol       Date:  2007-12-11       Impact factor: 3.478

Review 5.  Matrix metalloproteinases as modulators of inflammation.

Authors:  Anne M Manicone; John K McGuire
Journal:  Semin Cell Dev Biol       Date:  2007-07-10       Impact factor: 7.727

6.  A novel method to establish microglia-free astrocyte cultures: comparison of matrix metalloproteinase expression profiles in pure cultures of astrocytes and microglia.

Authors:  Stephen J Crocker; Ricardo F Frausto; J Lindsay Whitton; Richard Milner
Journal:  Glia       Date:  2008-08-15       Impact factor: 7.452

Review 7.  The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction.

Authors:  Britta Engelhardt; Lydia Sorokin
Journal:  Semin Immunopathol       Date:  2009-09-25       Impact factor: 9.623

8.  Increased cyclooxygenase activity impairs apoptosis of inflammatory neutrophils in mice lacking gelatinase B/matrix metalloproteinase-9.

Authors:  Elzbieta Kolaczkowska; Barbara Plytycz; Bernd Arnold; Helene Piccard; Ghislain Opdenakker
Journal:  Immunology       Date:  2008-10-29       Impact factor: 7.397

9.  Elevated MMP Expression in the MRL Mouse Retina Creates a Permissive Environment for Retinal Regeneration.

Authors:  Budd Tucker; Henry Klassen; Liu Yang; Dong Feng Chen; Michael J Young
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

10.  Association of matrix metalloproteinase-9 in eosinophilic meningitis of BALB/c mice caused by Angiostrongylus cantonensis.

Authors:  H H Lee; H L Chou; K M Chen; S C Lai
Journal:  Parasitol Res       Date:  2004-09-21       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.